SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Pharmalabs - Quaterly Results

05 Aug 2023 Evaluate
Revenue reduced marginally to stand at Rs. 3581.40 millions during the quarter ended June 2023. The figure stood at Rs. 3731.50 millions during the year-ago period.Profit for the quarter ended June 2023 increased merely by0.80% to Rs. 476.30  millions from Rs. 472.50 millions.OP of the company witnessed a marginal growth to 816.00 millions from 787.10 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 3581.40 3731.50 -4.02 3581.40 3731.50 -4.02 15112.50 9410.20 60.60
Other Income 48.60 0.00 0.00 48.60 0.00 0.00 12.80 25.10 -49.00
PBIDT 816.00 787.10 3.67 816.00 787.10 3.67 3096.20 1822.90 69.85
Interest 40.30 40.50 -0.49 40.30 40.50 -0.49 204.90 113.40 80.69
PBDT 775.70 746.60 3.90 775.70 746.60 3.90 2891.30 1709.50 69.13
Depreciation 154.40 124.10 24.42 154.40 124.10 24.42 557.70 372.30 49.80
PBT 621.30 622.50 -0.19 621.30 622.50 -0.19 2333.60 1337.20 74.51
TAX 145.00 150.00 -3.33 145.00 150.00 -3.33 616.30 270.00 128.26
Deferred Tax 35.00 22.50 55.56 35.00 22.50 55.56 95.00 45.00 111.11
PAT 476.30 472.50 0.80 476.30 472.50 0.80 1717.30 1067.20 60.92
Equity 453.10 453.10 0.00 453.10 453.10 0.00 453.10 455.60 -0.55
PBIDTM(%) 22.78 21.09 8.02 22.78 21.09 8.02 20.49 19.37 5.76

Aarti Pharmalabs Share Price

676.10 -20.50 (-2.94%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×